ORIGINAL RESEARCH article
Front. Health Serv.
Sec. Patient Safety
Development of a Trigger Tool to Identify Adverse Events and No-Harm Incidents in Paediatric Oncology: A Modified Delphi Process Using Expert Knowledge and User Experiences
Provisionally accepted- 1Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- 2Department of Pediatrics, Region Jonkopings lan, Jönköping, Sweden
- 3Department of Pediatrics, Institute of Clinical Sciences, Goteborgs universitet Sahlgrenska Akademin, Gothenburg, Sweden
- 4Jönköping Academy for Improvement of Health and Welfare, School of Health and Welfare, Jonkoping University, Jönköping, Sweden
- 5The Child and Health Care Service, Region Jonkopings lan, Jönköping, Sweden
- 6Futurum - the Academy for Health and Care, Region Jonkopings lan, Jönköping, Sweden
- 7School of Health and Welfare, Hogskolan Dalarna, Falun, Sweden
- 8Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background The objective of this study was to develop a Paediatric Oncology Trigger Tool aimed at facilitating the detection of adverse events and no-harm incidents in the patient process from specialised hospital care to home healthcare in paediatric oncology. The development of the trigger tool addresses the need for enhanced safety knowledge in paediatric oncology, particularly as the field has increasingly transitioned from inpatient admissions to day care and home healthcare settings. Existing trigger tools do not fully meet the specific requirements of paediatric oncology, where care is collaboratively provided by patients, parents and healthcare professionals. Materials and methods The study employed a multi-step process, including a literature search, a three-phase modified Delphi process, and the practical application of the trigger tool. All six Swedish paediatric oncology centres were represented in the Delphi process. Medical records were reviewed as part of the national multicentre study Patient Safety in Paediatric Oncology, which included participation from four out of six paediatric oncology centres, covering 64% of the population in Sweden. Data were collected from stakeholders representing the patient process from specialised hospital care to home healthcare in paediatric oncology, as well as from reviewers of medical records, and representatives with patient safety and trigger tool methodology expertise. Data were gathered through virtual meetings and web-based surveys, where the triggers were discussed and rated in terms of clinical relevance, comprehensibility and usefulness. Ratings were made using a four-point Likert scale. A dichotomisation process was used to assess consensus, defined as the proportion of respondents giving the same dichotomised rating. Result The key outcome was the development of a Paediatric Oncology Trigger Tool. The final tool consisted of 22 triggers with definitions and decision support information, designed to enhance understanding of patient safety in paediatric oncology. Conclusions The application of a multi-step development process resulted in a final context-specific trigger tool, the Paediatric Oncology Trigger Tool, addressing unique patient safety needs. The tool can be used in local safety initiatives aiming to improve safety for children with cancer. Additionally, this paper provides a transparent description of a systematic development process.
Keywords: adverse events, Modified Delphi process, No-harm incidents, Paediatric oncology, Patient Safety, Retrospective record review, trigger tool
Received: 23 Oct 2025; Accepted: 16 Dec 2025.
Copyright: © 2025 Engvall, Stenmarker, Andersson, Ros and Unbeck. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Charlotte Engvall
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
